Shanghai Pulmonary Hospital, Shanghai, China
Clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, explained in plain language.
-
New drug trial targets aggressive lung cancer after standard treatments fail
Disease control Recruiting nowThis study is testing whether the drug teniposide can help control advanced small cell lung cancer that has worsened despite standard chemotherapy. It is for patients whose cancer has a specific genetic feature called 'c-Myc-driven.' The main goal is to see if the drug shrinks tu…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo aims to make inoperable lung cancer operable
Disease control Recruiting nowThis study is testing whether a combination of two targeted drugs can shrink tumors enough to allow surgery in patients with a specific type of advanced lung cancer (EGFR-mutant). The goal is to see if giving these drugs first can make previously inoperable tumors removable. Rese…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study is testing a combination of two immunotherapy drugs plus standard chemotherapy given before surgery for patients with stage 2 or 3 non-small cell lung cancer. The goal is to see if this three-drug approach can shrink tumors more effectively before they are surgically r…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New hope for 'Uncuttable' lung tumors: drug combo aims to enable surgery
Disease control Recruiting nowThis study is testing whether a new drug called IBI363, combined with standard chemotherapy, can shrink stage 3 non-small cell lung cancer that is currently too advanced or complex to remove with surgery. The goal is to shrink the tumors enough so that surgery becomes a safe and …
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
AI could revolutionize cancer scans: creating PET images without extra radiation
Diagnosis Recruiting nowThis study is testing whether artificial intelligence can create PET scan images from regular CT scans to help doctors better diagnose and treat lung cancer. Researchers will enroll 10,000 lung cancer patients to see if these AI-generated images match real PET scans and provide a…
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
New Long-Lasting pain shot tested for lung surgery recovery
Symptom relief Recruiting nowThis study is testing whether a new, long-acting numbing medicine provides better pain relief after lung surgery than the standard version. Researchers will compare pain levels and opioid use in 210 patients who receive either the new extended-release medicine, the standard medic…
Phase: NA • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Better breathing after surgery? new drug trial aims to speed lung recovery
Symptom relief Recruiting nowThis study is testing which of two drugs helps patients recover their breathing ability faster after lung surgery. Researchers will compare sugammadex and neostigmine in 240 adults having a specific type of lung surgery. The main goal is to see which drug leads to better lung fun…
Phase: NA • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test 'Mini-Tumor' lab dish to match lung cancer patients with best drugs
Knowledge-focused Recruiting nowThis study aims to see if growing a patient's own lung cancer cells in a lab dish can help doctors choose the most effective treatment for them. Researchers will test drugs on these lab-grown cell clusters and see if the results match how well the patient responds to the same dru…
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Major study launches to map the hidden types of a chronic lung disease
Knowledge-focused Recruiting nowThis study aims to better understand the different patterns of bronchiectasis, a chronic lung disease, in Chinese adults. Researchers will collect detailed health information and samples from 1500 patients to identify distinct patient groups. The goal is to use this knowledge to …
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC